Literature DB >> 32520955

Exploring the choices and outcomes of older patients with advanced kidney disease.

Rhodri Pyart1, Justine Aggett1, Annwen Goodland1, Hayley Jones1, Alison Prichard1, Julia Pugh1, Nerys Thomas1, Gareth Roberts1.   

Abstract

A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004-2016) of a large single centre in the United Kingdom (1,216 patients), age, sex, comorbidity, poverty and frailty were used to predict choice of renal replacement therapy (RRT) over maximum conservative management (MCM). The impact of patient choice of RRT versus MCM was used to predict survival from the time of choice using multivariable Cox proportional hazards regression. Older age, female sex, greater poverty and greater frailty were associated with choosing MCM, whilst comorbidity had no significant impact on choice. At 5 years of follow up, 49% of all patients had died without receiving RRT. Over 70% of the patients choosing MCM died with better kidney function than the median level at which those starting RRT initiated treatment. Frailty and age were better predictors of survival than comorbidity and in patients with at least moderate frailty, RRT offered no survival benefit over MCM. In conclusion, analysing outcomes from the time of choice may improve shared decision making. Frailty should be routinely assessed and collected and further work may help predict which patients are unlikely to survive or progress to end stage renal disease and may not need to be burdened with making a pre-dialysis choice.

Entities:  

Year:  2020        PMID: 32520955     DOI: 10.1371/journal.pone.0234309

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

Review 1.  [Long-term physical and psychological consequences of chronic kidney disease].

Authors:  Friedrich Thaiss
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-03-21       Impact factor: 1.513

2.  Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Kidney Res Clin Pract       Date:  2021-12-10

3.  Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Kidney Res Clin Pract       Date:  2021-12-10

4.  Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis.

Authors:  Carlijn G N Voorend; Mathijs van Oevelen; Wouter R Verberne; Iris D van den Wittenboer; Olaf M Dekkers; Friedo Dekker; Alferso C Abrahams; Marjolijn van Buren; Simon P Mooijaart; Willem Jan W Bos
Journal:  Nephrol Dial Transplant       Date:  2022-07-26       Impact factor: 7.186

Review 5.  Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Korean J Intern Med       Date:  2022-06-03       Impact factor: 3.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.